ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement Press release LEIDEN, Netherlands and CAMBRIDGE, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. October 23, 2024
ProQR Strengthens Leading Intellectual Property Estate for ADAR-mediated RNA Editing Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. November 06, 2023
ProQR Announces Annual General Meeting of Shareholders and Provides Leadership Updates Press release Annual General Meeting of Shareholders to be held on June 30, 2022René Beukema joins management team as Chief Corporate Development Officer and General Counsel and is nominated to Management BoardGerard Platenburg to assume Chief Scientific Officer role, with le June 01, 2022
ProQR Announces Results for the Fourth Quarter and Full Year 2015 Press release LEIDEN, the Netherlands, Feb. 17, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. February 17, 2016
ProQR Therapeutics to Host Virtual R&D Event on March 29, 2023 Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. February 28, 2023
ProQR Supports Rare Disease Day 2018 and Honors Henri A. Termeer Press release LEIDEN, the Netherlands, Feb. 27, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. February 27, 2018
ProQR Announces Webcast of Presentation at Upcoming HC Wainwright BIOCONNECT Conference Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 18, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. December 18, 2020
ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. September 10, 2024
ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement Press release LEIDEN, the Netherlands and CAMBRIDGE, Mass., Oct. 25, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. October 25, 2024
ProQR Announces Conference Call to Discuss the Axiomer® RNA Editing Platform Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. September 08, 2021